[Co-tetroxazine: review and personal contributions].
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004338:Drug Combinations / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D011743:Pyrimidines / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013411:Sulfadiazine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D004338:Drug Combinations; D011743:Pyrimidines; D013411:Sulfadiazine; C026860:sulfadiazine, tetroxoprim drug combination
Co-tetroxazina: rassegna e contributi personali.